CeriBell, Inc (CBLL) — Quality & forensics
As of 2026-11-06 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 13
- Quality 22
- Growth 69
- Balance sheet 63
- Cash quality 52
- Capital allocation 15
- Momentum 91
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CBLL chart & overview
FAQ · from the current data · as of 2026-11-06
Quick answers
What is CeriBell, Inc's Closelooknet quality reading?
The composite reads 45/100 across 7 modules, as of 2026-11-06: valuation 13, quality 22, growth 69, balance sheet 63, cash quality 52, capital allocation 15, momentum 91. Closelooknet scores are research diary readings, not ratings or investment advice.
What is CeriBell, Inc's Altman Z-Score?
14.05, which sits in the safe zone (above 2.99) as of 2026-11-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is CeriBell, Inc's Piotroski F-Score?
3 of 9, as of 2026-11-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does CeriBell, Inc's Beneish M-Score indicate?
-2.57 — below the −1.78 manipulation-risk threshold, as of 2026-11-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM DexCom Incindustry
- CEVI.ST CellaVision ABindustry
- SECT-B.ST Sectra AB (publ)industry
- GMED Globus Medicalindustry
- SNN Smith & Nephew SNATS Incindustry
- SYK Stryker Corporationindustry
- ENOV Enovis Corpindustry
- MED.SW Medartis Holding AGindustry
- QSI QuantumSi Incindustry
- PHG Koninklijke Philips NV ADRindustry
- PACB Pacific Biosciences of Californiaindustry
- AXGN Axogen Incindustry
- DEMANT.CO Demant A/Sindustry
- EW Edwards Lifesciences Corpindustry
- SOON.SW Sonova H Agindustry
- STE STERIS plcindustry
- LIVN LivaNova PLCindustry
- ZBH Zimmer Biomet Holdings Incindustry
- 300760.SHE Shenzhen Mindray Bio-Medical Electronics Co Ltd Class Aindustry
- MDT Medtronic PLCindustry